E1

20. Lenschow DJ, Zeng Y, Thistlethwaite JR et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg [see comments]. Science 1992; 257(5071):789-792.

21. Parker DC, Greiner DL, Phillips NE et al. Survival of mouse pancreatic islet al-lografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc Natl Acad Sci U S A 1995; 92(21):9560-9564.

22. Larsen CP, Elwood ET, Alexander DZ et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381(6581):434-438.

23. Kirk AD, Burkly LC, Batty DS et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat Med 1999; 5(6):686-693.

24. Kenyon NS, Chatzipetrou M, Masetti M et al. Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc Natl Acad Sci U S A 1999; 96(14):8132-8137.

25. Graca L, Honey K, Adams E, Cobbold SP, Waldmann H. Cutting edge: Anti-cd154 therapeutic antibodies induce infectious transplantation tolerance. J immunol 2000; 165:4783-4786.

26. Chen ZK, Cobbold SP, Waldmann H et al. Amplification of natural regulatory immune mechanisms for transplantation tolerance. Transplantation 1996; 62(9):1200-1206.

27. Davies JD, Leong LY, Mellor A et al. T cell suppression in transplantation tolerance through linked recognition. J Immunol 1996; 156(10):3602-3607.

28. Honey K, Cobbold SP, Waldmann H. CD40 ligand blockade induces CD4+ T cell tolerance and linked suppression. J Immunol 1999; 163(9):4805-4810.

29. Mason D, Powrie F. Control of immune pathology by regulatory T cells. Curr Opin Immunol 1998; 10(6):649-655.

30. Fowell D, Mason D. Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potential. J Exp Med 1993; 177(3):627-636.

31. Powrie F, Mason D. OX-22high CD4+ T cells induce wasting disease with multiple organ pathology: prevention by the OX-22low subset. J Exp Med 1990; 172(6):1701-1708.

32. Seddon B, Mason D. The third function of the thymus. Immunol Today 2000; 21(2):95-99.

33. Powrie F, Carlino J, Leach MW et al. A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells. J Exp Med 1996; 183(6):2669-2674.

34. Asano M, Toda M, Sakaguchi N et al. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 1996; 184(2):387-396.

35. Suri-Payer E, Amar AZ, Thornton AM et al. CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 1998; 160(3):1212-1218.

36. Waldmann TA, O'Shea J. The use of antibodies against the IL-2 receptor in transplantation. Curr Opin Immunol 1998; 10(5):507-512.

37. Herbelin A, Gombert JM, Lepault F et al. Mature mainstream TCR alpha beta+CD4+ thymocytes expressing L-selectin mediate "active tolerance" in the nonobese diabetic mouse. J Immunol 1998; 161(5):2620-2628.

38. Read S, Mauze S, Asseman C et al. CD38+ CD45RB(low) CD4+ T cells: a population of T cells with immune regulatory activities in vitro. Eur J Immunol 1998; 28(11):3435-3447.

Delicious Diabetic Recipes

Delicious Diabetic Recipes

This brilliant guide will teach you how to cook all those delicious recipes for people who have diabetes.

Get My Free Ebook


Post a comment